BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37795368)

  • 21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
    Ceresini G; Corcione L; Michiara M; Sgargi P; Teresi G; Gilli A; Usberti E; Silini E; Ceda GP
    Cancer; 2012 Nov; 118(22):5473-80. PubMed ID: 22517468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends in Papillary and Follicular Thyroid Cancer Incidence from 1995 to 2019 in Adults in Denmark According to Education and Income.
    Sørensen SM; de la Cour CD; Maltesen T; Urbute A; Kjaer SK
    Thyroid; 2022 Aug; 32(8):972-982. PubMed ID: 35459415
    [No Abstract]   [Full Text] [Related]  

  • 24. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
    Sugitani I; Toda K; Yamamoto N; Sakamoto A; Fujimoto Y
    World J Surg; 2010 Jun; 34(6):1265-73. PubMed ID: 19953247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus.
    Fridman MV; Savva NN; Krasko OV; Zborovskaya AA; Mankovskaya SV; Schmid KW; Demidchik YE
    Thyroid; 2012 Oct; 22(10):1016-24. PubMed ID: 22947350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
    Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
    Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management outcomes of pediatric and adolescent papillary thyroid cancers with a brief review of literature.
    Palaniappan R; Krishnamurthy A; Rajaraman SS; Kumar RK
    Indian J Cancer; 2018; 55(1):105-110. PubMed ID: 30147104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics.
    Borda A; Zahan AE; Piciu D; Barbuș E; Berger N; Nechifor-Boilă A
    Endocrine; 2020 Mar; 67(3):630-642. PubMed ID: 31838728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
    Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
    Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
    Du L; Wang Y; Sun X; Li H; Geng X; Ge M; Zhu Y
    BMC Cancer; 2018 Mar; 18(1):291. PubMed ID: 29544469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma.
    Redlich A; Boxberger N; Schmid KW; Frühwald M; Rohrer T; Vorwerk P
    Pediatr Blood Cancer; 2012 Aug; 59(2):233-7. PubMed ID: 22184105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
    Iliadou PK; Effraimidis G; Konstantinos M; Grigorios P; Mitsakis P; Patakiouta F; Pazaitou-Panayiotou K
    Eur J Endocrinol; 2015 Dec; 173(6):827-33. PubMed ID: 26369577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Wiltshire JJ; Drake TM; Uttley L; Balasubramanian SP
    Thyroid; 2016 Nov; 26(11):1541-1552. PubMed ID: 27571228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor size and presence of metastases in differentiated thyroid cancer: comparing cohorts from two countries.
    van Velsen EFS; Peeters RP; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Visser WE; Verburg FA
    Eur J Endocrinol; 2023 Jun; 188(6):519-525. PubMed ID: 37314433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.
    de Melo TG; Zantut-Wittmann DE; Ficher E; da Assumpção LV
    J Endocrinol Invest; 2014 Dec; 37(12):1195-200. PubMed ID: 25037473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients.
    Hakala T; Kellokumpu-Lehtinen P; Kholová I; Holli K; Huhtala H; Sand J
    Scand J Surg; 2012; 101(4):301-6. PubMed ID: 23238509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological profile of childhood thyroid carcinoma in Ibadan, Southwestern Nigeria.
    Ajani MA; Omenai SA; Nwadiokwu JI; Salami AA
    Malawi Med J; 2020 Dec; 32(4):213-217. PubMed ID: 34457206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
    Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.